NSF SBIR/STTR Phase II + Fast-Track 2026: the $1.25M Award and the ~$2M Supplement Ladder
Phase I is the discovery grant. Phase II is the real money. The startups that get the most NSF SBIR funding are not the ones with the cleanest Phase I report; they are the ones who understood the Phase II supplement ladder before they wrote their Phase I proposal. Standard Phase II is up to $1,250,000 for 24 months. Stacked above it: a Phase IIB supplement ($50,000 to $500,000, matched against third-party investment), a TECP partnership supplement of up to 20% of the Phase II award, and TABA technical and business assistance. Fast-Track combines Phase I and Phase II into one application for companies with mature technical and commercialization signals. This guide maps the full ladder, the Fast-Track decision, the fixed submission deadlines, and a per-stage prep recipe. Whether you are closer to Phase I or ready for Fast-Track depends on the signals laid out below; our Grant Map shows which NSF solicitations are open now. For the prequel covering NSF Phase I mechanics, see our NSF SBIR Phase I 2026 guide.
- How much: Standard NSF SBIR Phase II is up to $1,250,000 over 24 months. The supplement ladder (Phase IIB, TECP, TABA) can take a single company to about $2 million of NSF non-dilutive funding.
- Supplement ladder: Phase IIB adds $50,000 to $500,000, capped at 50% of qualified third-party funds (at least $100,000 committed); TECP adds up to 20% of the Phase II award for work with a strategic partner; TABA adds up to about $50,000 of vendor-delivered business assistance.
- How to apply: Phase II is open only to Phase I awardees (or through Fast-Track) and cannot be cold-applied. Fast-Track combines Phase I and Phase II into one application, saving about 12 to 18 months, but requires technical proof and a commercialization story up front.
- Conversion odds: about 31% of SBIR Phase II proposals were funded in FY2022 (2,344 of 7,476, SBA annual report), with the commercialization plan usually the deciding factor.
Why Phase II is the real SBIR money
Phase I is feasibility. NSF Phase I awards are typically up to about $305,000 over six to twelve months for a small technical proof-of-concept and a customer-discovery sprint. Phase I is a tryout. Phase II is the build-out. The Phase II award is structured for the work that actually produces a product: extended prototyping, pilot manufacturing or pilot deployment, regulatory pre-submission packages where relevant, customer-paid pilots, and the commercialization plan that bridges to private capital. The dollar gap between Phase I and Phase II is roughly 3x. The strategic gap is bigger than that.
- ๐งช Phase II buys scope Phase I cannot. Pilot-line tooling, contract manufacturing engagement, IP filings beyond a provisional, ISO or other regulatory groundwork, and dedicated commercial staff time. Phase I budgets do not support these.
- ๐ค Phase II requires a Phase I award first. Outside of Fast-Track, NSF only accepts Phase II proposals from companies whose Phase I project is active or recently concluded. There is no cold-applying for Phase II.
- ๐ The supplement ladder is the actual moat. Phase IIB, TECP, and TABA stack on top of Phase II. Companies that map the ladder before Phase II kickoff capture supplements other companies miss because they did not know they existed.
- ๐ชช Commercialization signal is the gating filter. NSF Phase II reviewers care about technical merit and broader impact, but the deciding factor in Phase II conversion is usually the credibility of the commercialization plan: customer pipeline, market-pull letters, matching-investor signal, IP defensibility.
- ๐ Phase II is also the bridge to non-SBIR follow-on. A successful Phase II with Phase IIB matching investors is the cleanest non-dilutive setup for a seed-to-Series-A bridge. Companies that exit Phase II without matching investors miss that bridge.
The Phase II to IIB to TECP to TABA supplement ladder
This is the headline framework of the guide. Each rung on the ladder is a separate NSF mechanism with its own eligibility trigger and its own dollar ceiling. Stacked correctly, a single Phase II awardee can reach about $2 million of NSF funding before exiting the SBIR pipeline. Most companies leave money on the table because they treat Phase II as the end-state instead of the base of a stack.
Standard Phase II award, up to $1,250,000 over 24 months for full R&D build-out following a successful Phase I (NSF 26-510). Open to Phase I awardees, or through Fast-Track.
Supplement to an active Phase II of $50,000 to $500,000, limited to 50% of qualified third-party funds and requiring at least $100,000 of third-party commitments. Stacks on top of the base Phase II, not in place of it.
Supplement of up to 20% of the Phase II award for technical work that paves the way to a partnership with a strategic corporate partner or investor. (NSF offers no Commercialization Readiness Pilot; NIH and DoD run their own.)
Vendor-delivered commercialization help (market research, regulatory strategy, IP counsel, manufacturing scale-up). Cap set by SBA Policy Directive and the agency's program solicitation. Does not reduce the base R&D budget.
Fast-Track vs sequential Phase I to Phase II
Fast-Track is a combined Phase I plus Phase II application. If awarded, NSF commits Phase II funding at the time of the original decision, with Phase II disbursement triggered on Phase I milestone completion. Fast-Track collapses 12 to 18 months out of the calendar. Under NSF 26-510 a Fast-Track proposal can request up to $400,000 for the Phase I part and up to $1,155,000 for the Phase II part. It is also a sharper test: NSF wants substantial technical proof points and a documented commercialization story on day one, not after a Phase I tryout.
Fast-Track (combined Phase I+II)
- Eligibility
- Companies with mature technical data, prior public funding or peer-reviewed work, customer-discovery already done, and at least preliminary matching-investor or strategic-partner signal.
- Timeline
- Saves about 12 to 18 months versus sequential Phase I then Phase II. Phase II funds release on Phase I milestone completion.
- Risk
- Higher submission bar. If declined, the company has spent Fast-Track effort without falling back to a Phase I award. Resubmission as Phase I alone is allowed in a subsequent window.
- Commercialization signal
- Required up front. Letters of support from named customers or strategic partners, IP filings, market-sized TAM analysis, and a Phase IIB matching-investor narrative are effectively table stakes.
Sequential Phase I then Phase II
- Eligibility
- Open to companies with a credible technical idea, even if customer discovery and matching investors are not yet in place. Phase I is genuinely a feasibility tryout.
- Timeline
- Phase I 6 to 12 months. Phase II submitted at a deadline near the end of Phase I, with roughly 4 to 6 months from submission to award. Total elapsed time from initial submission to Phase II funds: roughly 18 to 24 months.
- Risk
- Lower per-application bar. Phase I results de-risk the Phase II decision for both NSF and the company. Phase II conversion is gated by Phase I performance and the commercialization plan built during Phase I.
- Commercialization signal
- Built during Phase I via the mandatory NSF customer-discovery curriculum (Beat-the-Odds Boot Camp) and optional I-Corps Teams. Letters of support assembled during Phase I.
NSF integrates I-Corps directly into the SBIR pipeline. Every Phase I awardee is required to participate in the Beat-the-Odds Boot Camp, NSF's mandatory customer-discovery training for Phase I projects. The optional I-Corps Teams program is a deeper 7-week customer-discovery curriculum that some companies use to strengthen the Phase II commercialization plan. For Fast-Track applicants, treating I-Corps Teams as a pre-application prep mechanism (run the curriculum during a prior award or as an independent academic partnership) is one of the cleanest ways to manufacture the customer-discovery evidence Fast-Track requires.
Submission deadlines and timing
Project Pitches go to NSF first, and full proposals then go in on fixed deadlines. Under NSF 26-510 the deadlines are November 4, 2026, March 4, 2027 and July 7, 2027, and after that the first Wednesday in November, the first Thursday in March and the first Wednesday in July each year. The table below maps what submits when; confirm dates on the active solicitation before planning a submission.
| Window | What submits | Topic coverage | Notes |
|---|---|---|---|
| Year-round | Project Pitch (3-page pre-screen) | All NSF SBIR/STTR topic areas | NSF responds within about three weeks on whether the company is invited to submit a full Phase I or Fast-Track proposal. |
| March 4, 2027 | Full Phase I and Fast-Track proposals | Spring cycle topic groupings | Submission requires an invitation from a successful Project Pitch. |
| July 7, 2027 | Full Phase I and Fast-Track proposals | Summer cycle topic groupings | Second major full-proposal window; identical mechanics to the spring cutoff. |
| Phase I end date + invitation | Phase II proposals (sequential path) | Tied to active Phase I project | Open to Phase I awardees on the same fixed deadlines (November 4, 2026 is the next); plan for the deadline nearest your Phase I end-date. |
| Throughout active Phase II | Phase IIB and TECP supplement requests (TABA is requested in the award budget) | Any active Phase II awardee | Supplements submitted through the program officer relationship and the active award mechanism, not through the open solicitation. |
The strategic implication: a company aiming for Fast-Track must have its Project Pitch in NSF's queue 4 to 6 months before the desired full-proposal cutoff, since the Pitch invitation gates the full submission. A company aiming for sequential Phase II must coordinate the Phase II submission window with the Phase I project end-date, which means thinking about Phase II in month 4 of Phase I, not month 11.
Per-stage application prep recipe
Each rung on the ladder has a different prep sequence. Treat the four cards below as the action checklist for the next 90 days of your SBIR program, not a backlog of someday work. For deeper proposal-writing fundamentals see our grant proposal writing guide and grant writing software comparison.
Phase I to Phase II transition
- Month 4 of Phase I: open the Phase II commercialization plan document; do not wait for month 9.
- Month 6: assemble a letter-of-support campaign with 5 to 10 named potential customers and 2 to 3 strategic partners.
- Month 8: complete the Beat-the-Odds Boot Camp customer-discovery outputs and convert them into Phase II narrative.
- Month 9 to 10: draft Phase II proposal, focusing technical narrative on what changed since the Phase I proposal.
- Submit Phase II at the fixed deadline nearest your Phase I end-date.
Fast-Track readiness
- Pre-application: confirm you have substantial technical proof points (often from a prior award, doctoral work, or self-funded prototyping).
- Pre-application: complete an I-Corps Teams curriculum or equivalent documented customer-discovery sprint.
- Pre-application: 8+ named customer or strategic-partner letters of support; at least one identifying a Phase IIB matching path.
- Project Pitch frame: lead with commercialization traction, not pure technical novelty. Fast-Track is decided on commercial credibility.
- If invited, draft combined Phase I+II proposal with explicit milestones gating Phase II disbursement.
Phase IIB matching-investor lineup
- Month 6 to 9 of Phase II: open a Phase IIB matching-investor pipeline; do not wait until month 18.
- Qualified-investor pool: strategic corporate partners, VC firms, customer-paid pilot contracts that NSF treats as qualified investment, and state matching programs.
- Document the matching commitment in a form NSF accepts (term sheet, signed strategic partnership, executed pilot contract).
- Coordinate the IIB submission with the program officer; supplements run through the active award mechanism.
- Verify the current matching ratio and ceiling on the NSF SBIR program solicitation before drafting.
TECP strategic-partner supplement
- Name the strategic corporate partner or investor the supplement work is meant to unlock.
- Define the technical work that partner needs to see (integration, validation, a joint prototype), sized to 20% of the Phase II award or less.
- Show how the work follows from Phase II results rather than restarting early-stage prototyping.
- Coordinate the request with your program officer; supplements run through the active award.
- Check the current terms on NSF's supplemental funding page before drafting.
See which NSF SBIR and STTR solicitations are open now
The GrantProbe Grant Map searches every open federal opportunity on Grants.gov. Set the agency to NSF and search "SBIR" or "STTR" to see what is open now, with deadlines and direct application links.
Open the Grant Map →Who this applies to
NSF SBIR/STTR is deliberately broad across deep-tech sectors. Four operator archetypes capture the bulk of NSF SBIR Phase II flow.
Hardware deeptech founder
Robotics, sensors, advanced materials, or instrumentation startup with a working Phase I prototype and pilot-line manufacturing as the Phase II goal.
Biotech with FDA path
Diagnostic, device, or therapeutic-adjacent startup where Phase II funds extended preclinical or regulatory pre-submission work.
Software / AI startup
AI infrastructure, vertical-AI applications, or core-ML research with Phase II focused on pilot deployments and scaled inference.
University spin-out
Faculty-founded or postdoc-founded company licensing IP from a university tech-transfer office, with STTR (not SBIR) as the eligible mechanism due to the university partnership.
Five failure modes that kill Phase II applications
Phase II is decided on technical merit and broader impact, but most declined Phase II proposals fail on commercialization fundamentals reviewers can identify in the first ten pages. The five failures below account for a disproportionate share of Phase II declines.
Technical narrative dominates the proposal with the commercialization plan treated as an appendix. Reviewers conclude the company has not thought about customers.
Only a provisional patent on file, with no clear claim language and no FTO analysis. Reviewers cannot defend a Phase II investment if the IP can be designed around.
Phase I produced controlled-environment data but nothing closer to the deployed environment. Phase II reviewers want to see a credible scale-up path.
No named potential customers in the Phase II package, or letters of support written in vague language that signals the customer has not actually evaluated the technology.
Company exits Phase II without a Phase IIB matching investor in place and loses access to the IIB supplement entirely. Pure timing failure.
Adjacent agency Phase II analogs are worth knowing. NIH SBIR Phase II has a $2,153,927 guideline (institutes can go higher with a waiver) and runs on its own omnibus solicitation. DOE sets Phase II amounts per topic in its own solicitations. DOD SBIR Phase II varies widely by component (Air Force, Navy, DARPA) and uses Direct-to-Phase-II and its own Commercialization Readiness Program. For broader federal R&D funding context across agencies, see our federal grants for startups guide and complete startup grants guide. For climate-adjacent SBIR topics, see climate and clean-energy small-business grants 2026. Rural-focused R&D companies should also evaluate USDA rural business grants. SBIR awardees also need to manage federal-contractor quarterly tax posture cleanly; our friends at CeoCult cover Q2 estimated taxes for federal R&D contractors. For the operational mechanics of registering on the federal grants portals before submission, see how to use Grants.gov.
Frequently asked questions
How much is NSF SBIR Phase II in 2026?
Can you skip Phase I with NSF SBIR Fast-Track?
What is Phase IIB matching funds in NSF SBIR?
How long does NSF SBIR Phase II take from submission to award?
What is TABA in NSF SBIR?
What is the NSF TECP supplement?
Bottom line
Phase I is the discovery grant. Phase II is the real money, and the supplement ladder above it (Phase IIB matching, TECP, TABA) is where the most-prepared companies pull away from the field. Decide Fast-Track vs sequential on the basis of commercialization signal, not impatience. Open the Phase II commercialization plan in month 4 of Phase I, not month 9. Line up your Phase IIB matching investor before Phase II kickoff. And verify the current NSF SBIR program solicitation and SBA SBIR/STTR Policy Directive before assuming any specific ceiling. To see which NSF and other federal solicitations are open now, search our Grant Map, and for the Phase I prequel see our NSF SBIR Phase I 2026 guide.
- NSF SBIR/STTR program page (current program solicitation, Project Pitch process, Phase I and Phase II mechanics).
- SBIR.gov (federal-wide SBIR/STTR portal, historical award database, agency program comparisons).
- SBA SBIR/STTR Policy Directive (master document governing TABA caps and supplement rules across all participating agencies).
- NSF America's Seed Fund (SBIR/STTR) (NSF-specific applicant resources, Beat-the-Odds Boot Camp, current solicitation links).
- GAO SBIR program reporting (federal-wide program evaluation and award-rate data).
- AAAS R&D Budget and Policy Program (federal R&D appropriations context for SBIR set-aside).
- NSF I-Corps program (Beat-the-Odds Boot Camp and I-Corps Teams curriculum).
- SBIR.gov award search (historical Phase I and Phase II award records by company, agency, and topic).